Monthly Injectable Buprenorphine May Reduce Staffing Time & Costs For OUD Treatment In Correctional Settings, Simulation Finds

A monthly injectable formulation of extended-release buprenorphine may reduce staffing time and associated costs for treating opioid use disorder (OUD) in correctional settings, according to a simulation model.

The model estimated staffing time and costs required to administer medications for opioid use disorder (MOUD) to 100 incarcerated individuals per month. Monthly hours for clinical professionals to administer and observe dosing and for security staff to accompany inmates ranged from 63 hours for Sublocade (17 clinical hours and 46 security hours) to 810 hours for oral buprenorphine (150 clinical hours and 660 security hours). Compared to other MOUD options, Sublocade . . .